Across Culture and Health Systems: America

  • Thuy M. VuEmail author
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 5)


Recognition of families with high penetrance of young-onset colorectal cancer has existed for over a century [1, 2, 3]. However, concerted efforts to define these high-penetrance diseases occurred much later [4, 5]. Once the molecular basis of hereditary colorectal cancer syndromes was elucidated, the clinical and research efforts toward identification, clinical care, and management of individuals at hereditary risk for colorectal cancer experienced an exponential growth within the last two decades.


Across Culture Health Systems America 


  1. 1.
    Cripps WH. Two cases of disseminated polypus of the rectum. Trans Path Soc London. 1882;33:165–8.Google Scholar
  2. 2.
    Bickersteth RA. Multiple polypi of the rectum occurring in a mother and child. St Barts Hosp Rep. 1890;26:299–301.Google Scholar
  3. 3.
    Warthin A. Heredity with reference to carcinoma. Arch Intern Med. 1913;12:546–55.CrossRefGoogle Scholar
  4. 4.
    Lynch HT, Krush AJ, Larsen AL. Heredity and multiple primary malignant neoplasms: six cancer families. Am J Med Sci. 1967;254:322–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Bussey HJR. Historical developments in familial polyposis coli. Sem Surg Oncol. 1987;3(2):67–70.CrossRefGoogle Scholar
  6. 6.
    U.S. Census Bureau, Current Population Reports, P60-235, Income, poverty, and health insurance coverage in the United States: 2007, U.S. Government Printing Office, Washington, DC; 2008. Available at:
  7. 7.
    The Henry J. Kaiser Family Foundation. How private health coverage works: a primer 2008 update. (#7766); 2008.Google Scholar
  8. 8.
    Centers for Medicare and Medicaid Services. Available at:
  9. 9.
    The Henry J. Kaiser Family Foundation. The uninsured: a primer, key facts about americans without health insurance (#7451); 2009.Google Scholar
  10. 10.
    Centers for Medicare and Medicaid Services. Accessed 30 Jul 2009.
  11. 11.
    American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol. 1996;14:1730–6.Google Scholar
  12. 12.
    American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. Clin Oncol. 2003;21(12):2397–406.CrossRefGoogle Scholar
  13. 13.
    National Comprehensive Cancer Network. Available at: Accessed 20 Aug 2009.
  14. 14.
    Trepanier A, Ahrens M, McKinnon W, Peters J, Stopfer J, Grumet SC, et al. Genetic cancer risk assessment and counseling: recommendations of the National Society of Genetic Counselors. J Genet Couns. 2004;13(2):83–114.PubMedCrossRefGoogle Scholar
  15. 15.
    Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, et al. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol. 2007;107(2):159–62.PubMedCrossRefGoogle Scholar
  16. 16.
    American Gastroenterological Association. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology. 2001;121:195–97.CrossRefGoogle Scholar
  17. 17.
    Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124(2):544–60.PubMedCrossRefGoogle Scholar
  18. 18.
    Epplein M, Koon KP, Ramsey SD, Potter JD. Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. J Clin Oncol. 2005;23(21):4713–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Zon RT, Goss E, Vogel VG, Chlebowski RT, Jatoi I, Robson ME, et al. American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment. Clin Oncol. 2009;27(6):986–93.CrossRefGoogle Scholar
  20. 20.
    Ruo L, Cellini C, La-Calle Jr JP, Murray M, Thaler HT, Quan SH, et al. Limitations of family cancer history assessment at initial surgical consultation. Dis Colon Rectum. 2001;44(1):98–103.PubMedCrossRefGoogle Scholar
  21. 21.
    Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol. 2004;2(9):813–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Brandt R, Ali Z, Sabel A, McHugh T, Gilman P. Cancer genetics evaluation: barriers to and improvements for referral. Genet Test. 2008;12(1):9–12.PubMedCrossRefGoogle Scholar
  23. 23.
    Dudley-Brown S, Freivogel M. Hereditary colorectal cancer in the gastroenterology clinic: how common are at-risk patients and how do we find them? Gastroenterol Nurs. 2009;32(1):8–16.PubMedCrossRefGoogle Scholar
  24. 24.
    Tyler Jr CV, Snyder CW. Cancer risk assessment: examining the family physician’s role. J Am Board Fam Med. 2006;19(5):468–77.PubMedCrossRefGoogle Scholar
  25. 25.
    National Conference of State Legislatures. Genetics and Health Insurance State Anti-Discrimination Laws. Accessed 6 Jul 2009.
  26. 26.
    Schroy PC, Barrison AF, Ling BS, Wilson S, Geller AC. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol. 2002;97:1031–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Batra S, Valdimarsdottir H, McGovern M, Itzkowitz S, Brown K. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol. 2002;97(3):729–33.PubMedCrossRefGoogle Scholar
  28. 28.
    Gammon A, Kohlmann W, Burt R. Can we identify the high-risk patients to be screened? A genetic approach. Digestion. 2007;76:7–19.PubMedCrossRefGoogle Scholar
  29. 29.
    Dudley-Brown S. The genetic family history assessment in gastroenterology nursing practice. Gastroenterol Nurs. 2004;27(3):107–10.PubMedCrossRefGoogle Scholar
  30. 30.
    Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Strecker MN, et al. A new definition of Genetic Counseling: National Society of Genetic Counselors’ Task Force report. Genet Couns. 2006;15(2):77–83.CrossRefGoogle Scholar
  31. 31.
    Smith M, Freivogel ME, Parrot S. National Society of Genetic Counselors, Inc. Professional status survey 2008. Available at: Accessed 9 March 2009.
  32. 32.
    Aronson M. Genetic counseling for hereditary colorectal cancer: ethical, legal and psychosocial issues. Surg Oncol Clin N Am. 2009;18(4):669–85.PubMedCrossRefGoogle Scholar
  33. 33.
    Stopfer JE. Genetic counseling and clinical cancer genetics services. Semin Surg Oncol. 2000;18(4):347–57.PubMedCrossRefGoogle Scholar
  34. 34.
    DeMarco TA, Smith KL, Nusbaum RH, Peshkin BN, Schwartz MD, Isaacs C. Practical aspects of delivering hereditary cancer risk counseling. Semin Oncol. 2007;34(5):369–78.PubMedCrossRefGoogle Scholar
  35. 35.
    Rubinstein WS, Weissman SM. Managing hereditary gastrointestinal cancer syndromes: the partnership between genetic counselors and gastroenterologists. Nat Clin Pract Gastroenterol Hepatol. 2008;5(10):569–82.PubMedCrossRefGoogle Scholar
  36. 36.
    Stadler MP, Mulvihill JJ. Cancer risk assessment and genetic counseling in an academic medical center: consultants’ satisfaction, knowledge and behavior in the first year. J Genet Couns. 1998;7(3):279–97.CrossRefGoogle Scholar
  37. 37.
    Informed Medical Decisions. Accessed 30 Jul 2009.
  38. 38.
    Church J, Kiringoda R, LaGuardia L. Inherited colorectal cancer registries in the United States: State of the Union. Dis Colon Rectum. 2004;47:674–8.PubMedCrossRefGoogle Scholar
  39. 39.
    UnitedHealthcare. Network Bulletin Volume 23; 2009. Accessed 30 Jul 2009.
  40. 40.
    Hall MA, Rich SS. Laws restricting health insurers’ use of genetic information: impact on genetic discrimination. Am J Hum Genet. 2000;66:293–307.PubMedCrossRefGoogle Scholar
  41. 41.
    Matloff ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN. What would you do? Specialists’ perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol. 2000;18(12):2484–92.PubMedGoogle Scholar
  42. 42.
    Lapham EV, Kozma C, Weiss JO. Genetic discrimination: perspectives of consumers. Science. 1996;274:621–4.PubMedCrossRefGoogle Scholar
  43. 43.
    Hall MA, Rich SS. Genetic privacy laws and patients’ fear of discrimination by health insurers: the view from genetic counselors. J Law Med Ethics. 2000;28(3):245–57.PubMedCrossRefGoogle Scholar
  44. 44.
    Pollitz K, Peshkin BN, Bangit E, Lucia K. Genetic discrimination in health insurance: current legal protections and industry practices. Inquiry. 2007;44(3):350–68.PubMedCrossRefGoogle Scholar
  45. 45.
    National Human Genome Research Institute. Federal Policy Recommendations Including HIPAA. Last reviewed: May 7 2009. Accessed 6 Jul 2009.
  46. 46.
    Genetic Information Nondiscrimination Act, Public Law 110-233, 122 Stat. 881 (final passage May 21 2008).Google Scholar
  47. 47.
    Hudson KL, Holohan MK, Collins FS. Keeping pace with the times – the Genetic Information Nondiscrimination Act of 2008. N Engl J Med. 2008;358(25):2661–3.PubMedCrossRefGoogle Scholar
  48. 48.
    Lowstuter KJ, Sand S, Blazer KR, MacDonald DJ, Banks KC, Lee CA, Schwerin BU, Juarez M, Uman GC, Weitzel JN. Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians. Genet Med 2008 Sept;10(9):691–8.Google Scholar
  49. 49.
    McKinnon W, Banks KC, Skely J, Kohlmann W, Bennett R, Shannon K, Larson-Haidle J, Ashakaga T, Weitzel JN, Wood M. Survey of unaffected BRCA and mismatch repair (MMR) mutation positive individuals. Fam Cancer. 2009;8(4):363–9.PubMedCrossRefGoogle Scholar
  50. 50.
    Apse KA, Biesecker BB, Giardiello FM, Fuller BP, Bernhardt BA. Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients. Genet Med. 2004 ­Nov-Dec;6(6):510–6.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Surgical OncologyUniversity of Texas, M. D. Anderson Cancer CenterHoustonUSA

Personalised recommendations